Search

Your search keyword '"Dalgard O."' showing total 358 results

Search Constraints

Start Over You searched for: Author "Dalgard O." Remove constraint Author: "Dalgard O." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
358 results on '"Dalgard O."'

Search Results

1. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

2. Impact of antibiotic therapy in patients with respiratory viral infections: a retrospective cohort study.

3. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

8. The present and future disease burden of hepatitis C virus (HCV) infections with todayʼs treatment paradigm – volume 2

9. Strategies to manage hepatitis C virus (HCV) infection disease burden – volume 2

10. Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 2

16. EASL Recommendations on Treatment of Hepatitis C 2018

24. EASL recommendations on treatment of hepatitis C: Final update of the series☆

35. A172 C-EDGE CO-STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOD AGONIST THERAPY (OAT)

37. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study

38. O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study

39. O21 HCV reinfection and injecting risk behaviour following elbasvir/grazoprevir treatment in patients on opioid agonist therapy: Co-STAR three year follow-up study

41. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study.

42. Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study

43. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study

44. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2

45. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2

46. Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2

47. Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe

49. Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study

50. Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

Catalog

Books, media, physical & digital resources